血脂异常
医学
代谢综合征
糖尿病
内科学
冠心病
疾病
内分泌学
出处
期刊:Advances in Cardiovascular Diseases
日期:2011-01-01
摘要
Dyslipidemia is coronary heart disease caused by multiple risk factors.Increasingly,evidence indicates that diabetes and metabolic syndrome give rise to mixed dyslipidemia.Evidence-based medicine has confirmed that a reduction to target level of low-density lipoprotein cholesterol constituted one of the primary methods for prevention of cardiovascular disease.Unfortunately,monotherapy for dyslipidemia for low-density lipoprotein is less effective.Accordingly,it is necessary to use combined therapy to treat patients with mixed dyslipidemia in order to increase efficacy and reduce side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI